51
Views
326
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

Regulation of Peroxisome Proliferator-Activated Receptor γ Expression by Adipocyte Differentiation and Determination Factor 1/Sterol Regulatory Element Binding Protein 1: Implications for Adipocyte Differentiation and Metabolism

, , , , , , , , & show all
Pages 5495-5503 | Received 28 Oct 1998, Accepted 12 May 1999, Published online: 28 Mar 2023
 

Abstract

Peroxisome proliferator-activated receptor γ (PPARγ) is a nuclear receptor implicated in adipocyte differentiation and insulin sensitivity. We investigated whether PPARγ expression is dependent on the activity of adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1 (ADD-1/SREBP-1), another transcription factor associated with both adipocyte differentiation and cholesterol homeostasis. Ectopic expression of ADD-1/SREBP-1 in 3T3-L1 and HepG2 cells induced endogenous PPARγ mRNA levels. The related transcription factor SREBP-2 likewise induced PPARγ expression. In addition, cholesterol depletion, a condition known to result in proteolytic activation of transcription factors of the SREBP family, induced PPARγ expression and improved PPRE-driven transcription. The effect of the SREBPs on PPARγ expression was mediated through the PPARγ1 and -3 promoters. Both promoters contain a consensus E-box motif that mediates the regulation of the PPARγ gene by ADD-1/SREBP-1 and SREBP-2. These results suggest that PPARγ expression can be controlled by the SREBP family of transcription factors and demonstrate new interactions between transcription factors that can regulate different pathways of lipid metabolism.

ACKNOWLEDGMENTS

The technical help of D. Cayet and C. Haby and the support of and/or discussion with A. Negro-Villar, R. Heyman, M. Leibowitz, D. Moller, S. Wright, and D. De Chaffoy are kindly acknowledged. We acknowledge the gift of materials from Samuel Wright and Alex Nadzan.

This work was supported by grants from INSERM, Région Nord-Pas-de-Calais, Institut Pasteur, Université de Lille II, ARC (no. 6403), and Ligand pharmaceuticals. J.A. is a research director with the CNRS, and K.S. is a research assistant with INSERM. L.F. was supported by the Janssen Research Foundation.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 61.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 265.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.